‹ Back to GLENMARK.NS

GLENMARK.NS Balance Sheet

Glenmark Pharmaceuticals Ltd.

Profit & Loss Balance Sheet Cash Flow

Balance Sheet · 4 years on file (FY2022-23 to FY2025-26) · fetched 2026-08-23 22:31
Line item FY2022-23 FY2023-24 FY2024-25 FY2025-26 Source (XBRL element)
Property, Plant and Equipment ₹39.04 Bn ₹31.18 Bn ₹33.19 Bn ₹38.90 Bn PropertyPlantAndEquipment
Capital Work-in-Progress ₹11.15 Bn ₹4.19 Bn ₹5.42 Bn ₹4.28 Bn CapitalWorkInProgress
Goodwill ₹0.74 Bn ₹0.67 Bn ₹0.70 Bn ₹0.83 Bn Goodwill
Other Intangible Assets ₹22.25 Bn ₹10.25 Bn ₹10.97 Bn ₹19.42 Bn OtherIntangibleAssets
Non-current Investments ₹0.45 Bn ₹7.90 Bn ₹0.56 Bn ₹0.42 Bn NoncurrentInvestments
Other Non-current Assets ₹1.54 Bn ₹1.49 Bn ₹1.79 Bn ₹4.28 Bn OtherNoncurrentAssets
Total Non-current Assets ₹94.98 Bn ₹69.31 Bn ₹67.54 Bn ₹86.08 Bn NoncurrentAssets
Inventories ₹29.78 Bn ₹25.13 Bn ₹30.29 Bn ₹34.31 Bn Inventories
Trade Receivables ₹40.99 Bn ₹18.58 Bn ₹33.42 Bn ₹49.63 Bn TradeReceivablesCurrent
Cash and Cash Equivalents ₹14.43 Bn ₹16.58 Bn ₹16.76 Bn ₹11.75 Bn CashAndCashEquivalents
Current Investments ₹0.00 Bn ₹0.00 Bn ₹0.00 Bn ₹0.00 Bn CurrentInvestments
Other Current Assets ₹11.54 Bn ₹12.24 Bn N/A ₹15.05 Bn OtherCurrentAssets
Total Current Assets ₹98.74 Bn ₹74.28 Bn ₹92.95 Bn ₹113.00 Bn CurrentAssets
Total Assets ₹193.72 Bn ₹143.59 Bn ₹160.50 Bn ₹199.08 Bn Assets
Equity Share Capital ₹0.28 Bn ₹0.28 Bn ₹0.28 Bn ₹0.28 Bn EquityShareCapital
Other Equity ₹94.46 Bn ₹78.20 Bn ₹88.21 Bn ₹104.84 Bn OtherEquity
Equity Attributable to Owners ₹94.74 Bn ₹78.48 Bn ₹88.49 Bn ₹105.12 Bn EquityAttributableToOwnersOfParent
Non-controlling Interests ₹3.65 Bn ₹-0.00 Bn ₹-0.00 Bn ₹-0.00 Bn NonControllingInterest
Total Equity ₹98.39 Bn ₹78.48 Bn ₹88.49 Bn ₹105.12 Bn Equity
Long-term Borrowings ₹38.52 Bn ₹0.00 Bn ₹5.13 Bn ₹0.00 Bn BorrowingsNoncurrent
Total Non-current Liabilities ₹44.87 Bn ₹6.92 Bn ₹12.33 Bn ₹30.20 Bn NoncurrentLiabilities
Short-term Borrowings ₹4.96 Bn ₹9.91 Bn ₹16.81 Bn ₹0.00 Bn BorrowingsCurrent
Trade Payables ₹23.92 Bn ₹25.36 Bn ₹25.80 Bn ₹37.44 Bn TradePayablesCurrent
Other Current Liabilities ₹1.95 Bn ₹2.44 Bn ₹1.99 Bn ₹8.62 Bn OtherCurrentLiabilities
Total Current Liabilities ₹50.46 Bn ₹58.19 Bn ₹59.67 Bn ₹63.76 Bn CurrentLiabilities
Total Equity and Liabilities ₹193.72 Bn ₹143.59 Bn ₹160.50 Bn ₹199.08 Bn EquityAndLiabilities

Every figure above is the exact value of the named XBRL element from GLENMARK.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).